Pressmeddelanden, rapporter och bolagsmeddelande för PILA PHARMA AB
Press Release: THE ONGOING RIGHTS ISSUE IN PILA PHARMA HAS ENTERED ITS LAST SUBSCRIPTION WEEK AND WILL END MONDAY 4 DECEMBER. THE LAST DAY OF TRADING SUBSCRIPTION RIGHTS IS WEDNESDAY 29 NOVEMBER
Press Release: PILA PHARMA WILL PRESENT AT "STORA AKTIEDAGARNA" IN STOCKHOLM TOMORROW, 27 NOVEMBER 2023 AT 8:00 CET
Press Release: PILA PHARMA ANNOUNCES PRECLINICAL RESEARCH COLLABORATION
Press Release: PILA PHARMA PUBLISHES INFORMATION MEMORANDUM
Note: PILA PHARMA INVITES TO AFTER-WORK INVESTOR MEETINGS
Report: PILA PHARMA PUBLISHES INTERIM REPORT (1 July - 30 September 2023)
Press Release: PILA PHARMA'S BOARD OF DIRECTORS HAS RESOLVED TO CARRY OUT A RIGHTS ISSUE OF SHARES OF APPROXIMATELY SEK 26.2 MILLION
Press Release: CORRECTION: Clarification and extended information on previous press release regarding convertible loans and their structure.
Press Release: PILA PHARMA announces capital infusion via convertible loans
Report: PILA PHARMA publishes interim report (1 April - 30 June 2023)